RIZZOTTO, Lara
 Distribuzione geografica
Continente #
NA - Nord America 2.298
EU - Europa 607
AS - Asia 365
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.272
Nazione #
US - Stati Uniti d'America 2.298
CN - Cina 244
DE - Germania 157
UA - Ucraina 144
TR - Turchia 109
IT - Italia 99
GB - Regno Unito 64
SE - Svezia 46
FI - Finlandia 37
BE - Belgio 17
FR - Francia 17
RU - Federazione Russa 17
RO - Romania 6
IN - India 2
KR - Corea 2
SG - Singapore 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
EU - Europa 1
IR - Iran 1
LT - Lituania 1
MY - Malesia 1
PT - Portogallo 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.272
Città #
Woodbridge 358
Chandler 253
Fairfield 252
Jacksonville 169
Ann Arbor 150
Houston 144
Seattle 110
Ashburn 108
Wilmington 100
Cambridge 97
Beijing 69
Izmir 62
New York 46
Ferrara 43
Nanjing 42
Princeton 38
Boardman 33
Shanghai 29
Milan 26
San Diego 23
Bremen 22
Brussels 17
Dearborn 17
Shenyang 17
Nanchang 16
Addison 15
Changsha 12
Los Angeles 12
Jiaxing 9
Tianjin 9
Guangzhou 8
Jinan 8
Auburn Hills 7
Mountain View 7
Zhengzhou 7
Norwalk 6
Orange 6
Falls Church 5
San Jose 5
Washington 5
Helsinki 4
Redwood City 4
Augusta 3
Des Moines 3
Hebei 3
Hefei 3
London 3
Paris 3
San Mateo 3
Dong Ket 2
Fuzhou 2
Monmouth Junction 2
Redmond 2
San Francisco 2
Tappahannock 2
Verona 2
Ardabil 1
Berlin 1
Bologna 1
Changchun 1
Chengdu 1
Chicago 1
Crotone 1
Frankfurt am Main 1
Hangzhou 1
Hounslow 1
Johor Bahru 1
Kunming 1
Lanzhou 1
Leawood 1
Lisbon 1
Manchester 1
Melbourne 1
Miami 1
New Bedfont 1
Ningbo 1
Philadelphia 1
Rockville 1
Seoul 1
Sofia 1
Taizhou 1
Venezia 1
Wuhan 1
Yellow Springs 1
Šiauliai 1
Totale 2.434
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 148
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 131
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 125
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 122
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 119
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 116
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 115
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 115
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 114
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 113
Rescue of coagulation factor VII function by the U1+5A snRNA 106
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 105
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 103
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 102
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 97
null 94
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 92
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 91
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 87
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 87
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 86
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 85
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 83
null 82
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 72
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 69
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 68
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 67
null 64
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 61
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 60
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 55
Non-conventional therapeutic strategies for inherited disorders of hemostasis 53
null 42
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 42
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 32
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 28
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 23
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 22
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 16
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 13
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 12
Totale 3.317
Categoria #
all - tutte 11.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019226 0 0 0 0 0 0 0 0 0 0 75 151
2019/2020663 107 19 19 94 46 83 55 66 51 80 30 13
2020/2021480 37 28 25 62 11 58 22 56 12 53 81 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024163 25 26 9 3 12 50 9 12 8 6 3 0
Totale 3.317